IDH2 and glioblastoma: IDH1 mutations occur at high frequency in WHO grade II and III astrocytoma (>80% of cases), precursor lesions of secondary glioblastoma, whereas IDH2 mutations occur largely in oligodendroglial tumors, with much lower frequency.